NO20084118L - Peptidisk veksthormonsekretutskillbare analoge forbindelser og fremstillinger derav - Google Patents
Peptidisk veksthormonsekretutskillbare analoge forbindelser og fremstillinger deravInfo
- Publication number
- NO20084118L NO20084118L NO20084118A NO20084118A NO20084118L NO 20084118 L NO20084118 L NO 20084118L NO 20084118 A NO20084118 A NO 20084118A NO 20084118 A NO20084118 A NO 20084118A NO 20084118 L NO20084118 L NO 20084118L
- Authority
- NO
- Norway
- Prior art keywords
- growth hormone
- hormone secretion
- secretable
- preparations
- analogous compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 102000018997 Growth Hormone Human genes 0.000 title abstract 2
- 108010051696 Growth Hormone Proteins 0.000 title abstract 2
- 239000000122 growth hormone Substances 0.000 title abstract 2
- 230000028327 secretion Effects 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 238000000126 in silico method Methods 0.000 abstract 1
- 238000002483 medication Methods 0.000 abstract 1
- 239000013589 supplement Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth hormone-releasing factor [GH-RF], i.e. somatoliberin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Immunology (AREA)
- Child & Adolescent Psychology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Fodder In General (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CU20060050A CU23558A1 (es) | 2006-02-28 | 2006-02-28 | Compuestos análogos a los secretagogos peptidicos de la hormona de crecimiento |
PCT/CU2007/000007 WO2007098716A1 (fr) | 2006-02-28 | 2007-02-28 | Composés analogues aux sécrétagogues peptidiques de l'hormone de croissance et préparations contenant ceux-ci |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20084118L true NO20084118L (no) | 2008-09-29 |
Family
ID=40130780
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20084118A NO20084118L (no) | 2006-02-28 | 2008-09-29 | Peptidisk veksthormonsekretutskillbare analoge forbindelser og fremstillinger derav |
Country Status (18)
Country | Link |
---|---|
US (1) | US8367620B2 (fr) |
EP (1) | EP1997827B1 (fr) |
JP (1) | JP5183496B2 (fr) |
KR (1) | KR101409277B1 (fr) |
CN (1) | CN101432294B (fr) |
AR (1) | AR059646A1 (fr) |
AU (1) | AU2007219569B2 (fr) |
BR (1) | BRPI0708366A2 (fr) |
CA (1) | CA2637593C (fr) |
CL (2) | CL2007000528A1 (fr) |
CU (1) | CU23558A1 (fr) |
ES (1) | ES2441441T3 (fr) |
MX (1) | MX2008011142A (fr) |
MY (1) | MY184130A (fr) |
NO (1) | NO20084118L (fr) |
RU (1) | RU2416618C2 (fr) |
WO (1) | WO2007098716A1 (fr) |
ZA (1) | ZA200807162B (fr) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2010052828A1 (fr) * | 2008-11-06 | 2010-05-14 | 国立大学法人名古屋大学 | Agent pharmaceutique destiné à des troubles myocardiques non ischémiques |
CU24473B1 (es) * | 2016-11-01 | 2020-02-04 | Centro De Ingenieria Genetica Y Biotecnologia Biocubafarma | Composición vacunal que comprende un péptido secretagogo de la hormona de crecimiento como adyuvante vacunal |
RU2734835C1 (ru) * | 2020-02-11 | 2020-10-23 | Федеральное государственное бюджетное учреждение науки Лимнологический институт Сибирского отделение Российской академии наук (ЛИН СО РАН) | Способ повышения жизнестойкости эмбрионов рыб в аквакультуре |
Family Cites Families (92)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3239345A (en) | 1965-02-15 | 1966-03-08 | Estrogenic compounds and animal growth promoters | |
US4411890A (en) | 1981-04-14 | 1983-10-25 | Beckman Instruments, Inc. | Synthetic peptides having pituitary growth hormone releasing activity |
US4036979A (en) | 1974-01-25 | 1977-07-19 | American Cyanamid Company | Compositions containing 4,5,6,7-tetrahydrobenz[b]thien-4-yl-ureas or derivatives and methods of enhancing growth rate |
EP0400051B1 (fr) | 1988-01-28 | 1995-05-10 | Polygen Holding Corporation | Composes polypeptidiques ayant une activite de liberation d'une hormone de croissance |
AU628322B2 (en) | 1988-01-28 | 1992-09-17 | Eastman Kodak Company | Polypeptide compounds having growth hormone releasing activity |
JP2670680B2 (ja) | 1988-02-24 | 1997-10-29 | 株式会社ビーエムジー | 生理活性物質含有ポリ乳酸系微小球およびその製造法 |
JPH06503320A (ja) | 1990-10-25 | 1994-04-14 | ジェネンテク,インコーポレイテッド | 再活性化酸素種に対する防御剤の使用 |
US5663146A (en) | 1991-08-22 | 1997-09-02 | Administrators Of The Tulane Educational Fund | Polypeptide analogues having growth hormone releasing activity |
JPH08503213A (ja) | 1992-11-06 | 1996-04-09 | メルク エンド カンパニー インコーポレーテッド | 成長ホルモンの放出を促進する置換ジペプチド同族体 |
US5726319A (en) | 1992-11-06 | 1998-03-10 | Merck & Co., Inc. | Biphenyl substituted dipeptide analogs promote release of growth hormone |
WO1994013696A1 (fr) | 1992-12-11 | 1994-06-23 | Merck & Co., Inc. | Spiro-piperidines et homologues favorisant la liberation de l'hormone de croissance |
US5536716A (en) | 1992-12-11 | 1996-07-16 | Merck & Co., Inc. | Spiro piperidines and homologs which promote release of growth hormone |
PL314003A1 (en) | 1993-10-19 | 1996-08-05 | Merck & Co Inc | Combination of bisulphonates and substances enhancing secretion of growth hormone |
US5492916A (en) | 1993-12-23 | 1996-02-20 | Merck & Co., Inc. | Di- and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
US5494919A (en) | 1993-11-09 | 1996-02-27 | Merck & Co., Inc. | 2-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
HUT74733A (en) | 1993-11-09 | 1997-02-28 | Merck & Co Inc | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
JPH09505601A (ja) | 1993-11-24 | 1997-06-03 | メルク エンド カンパニー インコーポレーテッド | インドリル基含有化合物類および成長ホルモン放出を促進するためのそれらの使用 |
US5721251A (en) | 1993-12-10 | 1998-02-24 | Merck & Co., Inc. | Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone |
IL112112A (en) | 1993-12-23 | 2000-06-29 | Novo Nordisk As | Peptides with growth hormone releasing properties and pharmaceutical compositions containing them |
ATE202785T1 (de) | 1993-12-23 | 2001-07-15 | Novo Nordisk As | Verbindungen mit wachstumshormon-freisetzenden eigenschaften |
US5721250A (en) | 1993-12-23 | 1998-02-24 | Merck & Co. Inc. | Di-and tri-substituted piperidines, pyrrolidines and hexahydro-1H-azepines promote release of growth hormone |
WO1995034311A1 (fr) | 1994-06-13 | 1995-12-21 | Merck & Co., Inc. | Compose de piperazine provoquant la liberation de l'hormone de croissance |
US5783582A (en) | 1994-07-20 | 1998-07-21 | Merck & Co., Inc. | Piperidines and hexahydro-1H-azepines spiro substituted at the 4-position promote release of growth hormone |
US5798337A (en) | 1994-11-16 | 1998-08-25 | Genentech, Inc. | Low molecular weight peptidomimetic growth hormone secretagogues |
WO1996022996A1 (fr) | 1995-01-25 | 1996-08-01 | Nippon Chemiphar Co., Ltd. | Derives de dihydrophenazine |
PL186511B1 (pl) | 1995-01-27 | 2004-01-30 | Novo Nordisk As | Nowe związki peptydowe, kompozycje farmaceutycznedo pobudzania uwalniania hormonu wzrostu i zastosowanie tych związków do wytwarzania leku do pobudzania uwalniania hormonu wzrostu |
AU4534696A (en) | 1995-02-09 | 1996-08-27 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1996024580A1 (fr) | 1995-02-09 | 1996-08-15 | Novo Nordisk A/S | Composes favorisant la liberation de l'hormone de croissance |
US5559128A (en) | 1995-04-18 | 1996-09-24 | Merck & Co., Inc. | 3-substituted piperidines promote release of growth hormone |
AU5486396A (en) | 1995-04-19 | 1996-11-07 | Merck & Co., Inc. | Process for the preparation of spiroindolines |
WO1996035713A1 (fr) | 1995-05-08 | 1996-11-14 | Pfizer, Inc. | Dipeptides stimulant la liberation de l'hormone de croissance |
JP3133073B2 (ja) | 1995-05-29 | 2001-02-05 | ファイザー・インコーポレーテッド | 成長ホルモンの放出を促進するジペプチド類 |
BR9608909A (pt) | 1995-06-22 | 1999-03-02 | Novo Nordisk As | Composto composição farmacêutica processos para estimular a liberação do hormônio do crescimento da patuitária e aumentar a velocidade e extensão do crescimento dos animais para aumentar a produção de leite ou lã de animais ou para para doenças e uso do composto |
WO1997006803A1 (fr) | 1995-08-21 | 1997-02-27 | Eli Lilly And Company | 2-acylaminopropanamides en tant que secretagogues d'hormones de croissance |
ZA966891B (en) | 1995-08-21 | 1998-02-16 | Lilly Co Eli | 2-acylaminopropanamines as growth hormone secretagogues. |
EP0766966A3 (fr) | 1995-09-08 | 2001-02-28 | Eli Lilly And Company | Méthode de traitement de la résistance à l'insuline |
AU7169696A (en) | 1995-09-26 | 1997-04-17 | Merck & Co., Inc. | 3-spirolactam, 3-spiroamino, 3-spirolactone and 3-spirobenzopyran piperidines and pyrrolidines promote release of growth hormone |
AU7522896A (en) | 1995-10-27 | 1997-05-15 | Merck & Co., Inc. | Wet granulation formulation of a growth hormone secretagogue |
HUP9902095A3 (en) | 1995-10-27 | 2001-05-28 | Merck & Co Inc | New process for the preparation of a growth hormone secretagogue |
US5767124A (en) | 1995-10-27 | 1998-06-16 | Merck & Co., Inc. | Polymorphic forms of a growth hormone secretagogue |
US5723616A (en) | 1995-10-27 | 1998-03-03 | Merck & Co., Inc. | Process for the preparation of a growth hormone secretagogue |
WO1997021730A1 (fr) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Famille de recepteurs secretagogues d'hormones de croissance |
CA2240186A1 (fr) | 1995-12-13 | 1997-06-19 | Merck & Co., Inc. | Dosage des recepteurs secretagogues d'hormones de croissance |
WO1997022367A1 (fr) | 1995-12-20 | 1997-06-26 | Merck & Co., Inc. | Secretagogue d'hormone de croissance radiomarque |
IT1277113B1 (it) | 1995-12-20 | 1997-11-04 | Romano Deghenghi | Composti oligopeptidici contenenti d-2-alchiltriptofano in grado di promuovere la liberazione dell'ormone della crescita |
CZ195098A3 (cs) | 1995-12-22 | 1998-10-14 | Novo Nordisk A/S | Sloučeniny uvolňující růstový hormon |
TW432073B (en) | 1995-12-28 | 2001-05-01 | Pfizer | Pyrazolopyridine compounds |
AU2334097A (en) | 1996-03-21 | 1997-10-10 | Merck & Co., Inc. | 4-spiroindoline piperidines promote release of growth hormone |
WO1997036873A1 (fr) | 1996-04-03 | 1997-10-09 | Merck & Co., Inc. | Piperidines, pyrrolidines et hexahydro-1h-azepines declenchant la liberation de l'hormone de croissance |
SE9601397D0 (sv) | 1996-04-12 | 1996-04-12 | Pharmacia Ab | Use of growth hormone |
AU2382097A (en) | 1996-04-19 | 1997-11-12 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
US5919777A (en) | 1996-04-24 | 1999-07-06 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
PL329413A1 (en) | 1996-04-24 | 1999-03-29 | Novo Nordisk As | Chemical compounds exhibiting properties capable to cause growth hormone release |
AU2931997A (en) | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
CA2253390A1 (fr) | 1996-05-07 | 1997-11-13 | Merck & Co., Inc. | Stimulation du sommeil avec un secretagogue d'hormone de croissance |
AU2764797A (en) | 1996-05-14 | 1997-12-05 | Novo Nordisk A/S | Somatostatin agonists and antagonists |
US6071926A (en) | 1996-05-22 | 2000-06-06 | Arch Development Corporation | Sleep quality improvement using a growth hormone secretagogue |
IL126983A0 (en) | 1996-05-31 | 1999-09-22 | Novo Nordisk As | Growth hormone components and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis |
US5922770A (en) | 1996-07-22 | 1999-07-13 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
AU4342097A (en) | 1996-09-13 | 1998-04-02 | Merck & Co., Inc. | Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone |
AU4993497A (en) | 1996-10-25 | 1998-05-22 | Merck & Co., Inc. | Convergent process for the preparation of a growth hormone secretagogue |
SE9703929D0 (sv) | 1996-11-22 | 1997-10-28 | Pharmacia & Upjohn Ab | Therapeutical use and method |
AU6747498A (en) | 1997-04-11 | 1998-11-11 | Sumitomo Pharmaceuticals Company, Limited | Benzene derivatives |
JP2000514838A (ja) | 1997-05-14 | 2000-11-07 | 藤沢薬品工業株式会社 | 成長ホルモンの放出を促進するピペリジノ誘導体 |
US5861149A (en) | 1997-06-04 | 1999-01-19 | Polyheal Ltd. | Methods for wound treatment |
WO1998058950A1 (fr) | 1997-06-20 | 1998-12-30 | Novo Nordisk A/S | Composes ayant des proprietes de liberation de l'hormone de croissance |
ATE356139T1 (de) | 1997-06-25 | 2007-03-15 | Pfizer | Dipeptidderivate zur förderung der sekretion von wachstumshormon |
UA64751C2 (uk) | 1997-06-25 | 2004-03-15 | Пфайзер Продактс Інк. | Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти) |
UA53716C2 (uk) | 1997-06-25 | 2003-02-17 | Пфайзер Продактс Інк. | Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти) |
ZA987383B (en) | 1997-08-19 | 2000-02-17 | Lilly Co Eli | Treatment of congestive heart failure with growth hormone secretagogues. |
US6864250B1 (en) | 1997-08-22 | 2005-03-08 | Kaken Pharmaceutical Co., Ltd. | N-acylated lipophilic amino acid derivatives |
AU766305B2 (en) | 1998-01-16 | 2003-10-16 | Novo Nordisk A/S | Compounds with growth hormone releasing properties |
WO1999039730A1 (fr) | 1998-02-09 | 1999-08-12 | Kaken Pharmaceutical Co., Ltd. | Preparation a administration orale contenant des peptides favorisant la secretion d'hormone de croissance |
WO1999045029A1 (fr) | 1998-03-03 | 1999-09-10 | Novo Nordisk A/S | Nouvelles formes salines d'acide (2e)- 5-amino- methylhex- 2-enoique-n-methyl-n-((1r)-1-(n- methyl-n-((1r)-1(methylcarbamoyl)-2- phenylethyl)carbamoyl)-2- (2-naphtyl)ethyl)amide |
DE69941255D1 (de) | 1998-05-11 | 2009-09-24 | Novo Nordisk As | Verbindungen mit wachstumshormon freisetzenden eigenschaften |
WO1999064456A1 (fr) | 1998-06-09 | 1999-12-16 | Novo Nordisk A/S | Procede de preparation d'un compose presentant des proprietes de liberation de l'hormone de croissance |
ZA993975B (en) | 1998-06-16 | 2000-12-15 | Pfizer Prod Inc | Combination therapy for musculoskeletal frailty. |
AU3342099A (en) | 1998-06-16 | 2000-01-05 | Pfizer Products Inc. | Therapeutic combinations of (selective) estrogen receptor modulators (serm) and growth hormone secretagogues (ghs) for treating musculoskeletal frailty |
IL140044A0 (en) | 1998-06-30 | 2002-02-10 | Novo Nordisk As | Compounds with growth hormone releasing properties |
ES2237135T3 (es) | 1998-08-20 | 2005-07-16 | Sumitomo Pharmaceuticals Company, Limited | Derivados de oxindol como liberadores de la hormona del crecimiento. |
US6358951B1 (en) | 1998-08-21 | 2002-03-19 | Pfizer Inc. | Growth hormone secretagogues |
EP1258250B1 (fr) | 1999-12-28 | 2005-09-14 | Kaken Pharmaceutical Co., Ltd. | Medicaments protegeant les nerfs |
JP2004514651A (ja) | 2000-05-30 | 2004-05-20 | メルク エンド カムパニー インコーポレーテッド | グレリン類似体 |
DE60140285D1 (de) | 2000-05-31 | 2009-12-10 | Pfizer Prod Inc | Verwendung von Wachstumshormonsekretagoga zur Förderung der Beweglichkeit des Verdauungstrakts |
ATE302181T1 (de) | 2000-06-13 | 2005-09-15 | Zentaris Gmbh | Verbindungen zur stimulation der sekretion von wachstumshormonen |
EP1297839A4 (fr) | 2000-06-23 | 2005-12-07 | Kaken Pharma Co Ltd | Agents therapeutiques et prophylactiques destines a l'insuffisance cardiaque |
ITMI20011445A1 (it) | 2001-07-06 | 2003-01-06 | Europ Geie | Analoghi della cortistantina capaci di legarsi selettivamente ai recettori dei secretagoghi dell'ormone della crescita |
HK1077740A1 (en) | 2001-12-20 | 2006-02-24 | Ct Ingenieria Genetica Biotech | Use of epidermal growth factor in the manufacture of a pharmaceutical injection composition for preventing diabetic limb amputation |
US7476653B2 (en) | 2003-06-18 | 2009-01-13 | Tranzyme Pharma, Inc. | Macrocyclic modulators of the ghrelin receptor |
WO2005039625A1 (fr) | 2003-10-28 | 2005-05-06 | Rheoscience A/S | Agonistes du recepteur des secretagogues de l'hormone de croissance |
CA2544602A1 (fr) | 2003-11-04 | 2005-05-26 | Elixir Pharmaceuticals, Inc. | Composes therapeutiques et utilisations correspondantes |
WO2005048916A2 (fr) | 2003-11-20 | 2005-06-02 | Biovitrum Ab | Nouvelles carbolines-beta en tant qu'antagonistes de recepteur de secretagogue d'hormone de croissance |
-
2006
- 2006-02-28 CU CU20060050A patent/CU23558A1/es active IP Right Grant
-
2007
- 2007-02-27 AR ARP070100806A patent/AR059646A1/es not_active Application Discontinuation
- 2007-02-27 CL CL2007000528A patent/CL2007000528A1/es unknown
- 2007-02-28 CA CA2637593A patent/CA2637593C/fr not_active Expired - Fee Related
- 2007-02-28 KR KR1020087023543A patent/KR101409277B1/ko not_active IP Right Cessation
- 2007-02-28 US US12/281,085 patent/US8367620B2/en not_active Expired - Fee Related
- 2007-02-28 WO PCT/CU2007/000007 patent/WO2007098716A1/fr active Application Filing
- 2007-02-28 CN CN2007800153594A patent/CN101432294B/zh not_active Expired - Fee Related
- 2007-02-28 BR BRPI0708366-1A patent/BRPI0708366A2/pt not_active IP Right Cessation
- 2007-02-28 ES ES07711101.1T patent/ES2441441T3/es active Active
- 2007-02-28 RU RU2008138569/10A patent/RU2416618C2/ru not_active IP Right Cessation
- 2007-02-28 MY MYPI20083178A patent/MY184130A/en unknown
- 2007-02-28 EP EP07711101.1A patent/EP1997827B1/fr not_active Not-in-force
- 2007-02-28 JP JP2008556643A patent/JP5183496B2/ja not_active Expired - Fee Related
- 2007-02-28 AU AU2007219569A patent/AU2007219569B2/en not_active Ceased
- 2007-02-28 MX MX2008011142A patent/MX2008011142A/es active IP Right Grant
-
2008
- 2008-08-19 ZA ZA200807162A patent/ZA200807162B/xx unknown
- 2008-09-29 NO NO20084118A patent/NO20084118L/no not_active Application Discontinuation
-
2016
- 2016-06-24 CL CL2016001648A patent/CL2016001648A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
US20100055118A1 (en) | 2010-03-04 |
WO2007098716A1 (fr) | 2007-09-07 |
JP5183496B2 (ja) | 2013-04-17 |
EP1997827A1 (fr) | 2008-12-03 |
CL2016001648A1 (es) | 2017-02-24 |
RU2008138569A (ru) | 2010-04-10 |
BRPI0708366A2 (pt) | 2011-05-24 |
AU2007219569B2 (en) | 2012-03-15 |
CU23558A1 (es) | 2010-07-20 |
CN101432294A (zh) | 2009-05-13 |
MX2008011142A (es) | 2008-09-08 |
WO2007098716A8 (fr) | 2008-12-18 |
CL2007000528A1 (es) | 2008-01-18 |
JP2009528303A (ja) | 2009-08-06 |
AU2007219569A1 (en) | 2007-09-07 |
CN101432294B (zh) | 2013-09-11 |
RU2416618C2 (ru) | 2011-04-20 |
ES2441441T3 (es) | 2014-02-04 |
AR059646A1 (es) | 2008-04-16 |
ZA200807162B (en) | 2009-06-24 |
US8367620B2 (en) | 2013-02-05 |
CA2637593A1 (fr) | 2007-09-07 |
KR20080110763A (ko) | 2008-12-19 |
EP1997827B1 (fr) | 2013-10-09 |
KR101409277B1 (ko) | 2014-06-24 |
CA2637593C (fr) | 2015-04-14 |
MY184130A (en) | 2021-03-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20070983L (no) | Stabil injiserbar blanding av alfa-tokoferylsuksinat, analoger og salter derav | |
CA2818969A1 (fr) | Modules de coiffage n-terminal ameliores pour des proteines de repetitions d'ankyrine concues | |
NO20072352L (no) | Forbindelser og sammensetninger som inhibitorer av cannabinoidreceptor 1-aktivitet | |
WO2008002571A3 (fr) | Inhibiteurs de la protéine humaine tyrosine phosphatase et leurs procédés d'utilisation | |
NO20090596L (no) | Antivirale fosfinatforbindelser | |
MY158438A (en) | Antibodies against human angiopoietin 2 | |
EP4238420A3 (fr) | Compositions de protéines de lactosérum, procédés et utilisations | |
EP3412304A3 (fr) | Épitopes agonistes hla-a24 de l'oncoprotéine muc1-c et compositions et procédés d'utilisation | |
WO2011013133A3 (fr) | Nouvelles compositions biopesticides et leur procédé d'isolement et de caractérisation | |
WO2008002569A3 (fr) | Inhibiteurs de la protéine humaine tyrosine phosphatase et leurs procédés d'utilisation | |
CY1115413T1 (el) | Ανασυνδυασμενη fsh η οποια περιλαμβανει αλφα 2,3- και αλφα 2',6-sialylation | |
UA96308C2 (ru) | Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение | |
MX2009004714A (es) | Derivados de pirazol fusionado 3-aminocarbonilo sustituidos como moduladores de proteina cinasa. | |
NO20065984L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
NO20085183L (no) | Stabiliserte insulinlignende vekstfaktorpolypeptider | |
WO2008085828A3 (fr) | Modulateurs peptidiques de l'angiogenèse et leur utilisation | |
WO2009025196A1 (fr) | Peptide foxm1 et agent médicinal le comprenant | |
NO20064771L (no) | 2-pyridyl substituerte imidazoler som ALK5 og/eller ALK4 inhibitorer | |
NO20065983L (no) | Forbindelser og sammensetninger som PPAR modulatorer | |
WO2008057550A3 (fr) | Stabilisation de vaccins par lyophilisation | |
MX346950B (es) | Reovirus que tienen secuencias modificadas. | |
EA201170659A1 (ru) | Антитела к рецептору ii tgf-вета | |
WO2008034142A3 (fr) | Synthèse, procédés d'utilisation et compositions de cycloalkylméthylamines | |
MX2010001723A (es) | Formulaciones de anticuerpos y moleculas de fusion-fc usando policationes. | |
NO20075752L (no) | Kimeriske proteiner, deres fremstilling og farmasoytiske sammensetninger som inneholder dem |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |